HDAC2 and chronic obstructive pulmonary disease: Mechanistically, this has been explained by a decreased expression and activity of histone-deacetylase-2 (HDAC2) in AM of COPD subjects that lead to a failure of activated glucocorticoid receptors to block the activity of the transcription factor NF-κB.